Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

J Am Heart Assoc. 2023 Apr 18;12(8):e028869. doi: 10.1161/JAHA.122.028869. Epub 2023 Apr 12.

Mohammed Essa¹, Joseph S Ross^{2

3

4}, Sanket S Dhruva⁵, Nihar R Desai⁶, Robert W Yeh⁷, Kamil F Faridi⁶

¹ New England Heart and Vascular Institute Catholic Medical Center Manchester NH USA.
² Center for Outcomes Research and Evaluation, Yale New Haven Health System New Haven CT USA.
³ Section of General Internal Medicine, Department of Medicine, Yale School of Medicine New Haven CT USA.
⁴ Department of Health Policy and Management, Yale School of Public Health New Haven CT USA.
⁵ Section of Cardiology, Department of Medicine University of California at San Francisco School of Medicine San Francisco CA USA.
⁶ Section of Cardiovascular Medicine, Department of Medicine Yale School of Medicine; Center for Outcomes Research and Evaluation, Yale New Haven Health System New Haven CT USA.
⁷ Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA USA.

No abstract available

Keywords: clopidogrel; medication costs; prasugrel; ticagrelor.

Publication types